References
- Williamson EJ, Walker AJ, Bhaskaran K. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584:430–436.
- Aries JA, Davies JK, Auer RL, et al. Clinical outcome of coronavirus disease 2019 in haemato‐oncology patients. Br J Haematol. 2020;190(2):bjh.16852.
- He W, Chen L, Chen L, et al. COVID-19 in persons with haematological cancers. Leukemia. 2020;34(6):1637–1645.
- Malard F, Genthon A, Brissot E, et al. COVID-19 outcomes in patients with hematologic disease. Bone Marrow Transplantation. 2020;55:2180–2184.
- Martín‐Moro F, Marquet J, Piris M, et al. Survival study of hospitalised patients with concurrent COVID‐19 and haematological malignancies. Br J Haematol. 2020;190(1):e16–e20.
- Banerjee A, Pasea L, Harris S, et al. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. The Lancet. 2020;395(10238):1715–1725.
- Jin XH, Zheng KI, Pan KH, et al. COVID-19 in a patient with chronic lymphocytic leukaemia. The Lancet Haematology. 2020;7(4):e351–e352.
- Paneesha S, Pratt G, Parry H, et al. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia. Leuk Res. 2020;93:106366.